Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
78
days
Nasal‐type Extranodal Natural Killer (NK)/T‐cell Lymphoma Mimicking ANCA‐associated Vasculitis
AuthorsHakeem Asad; Kenneth J. Warrington
Affiliations1. Department of Internal Medicine, Mayo Clinic Rochester Minnesota USA; 2. Division of Rheumatology, Mayo Clinic Rochester Minnesota USA
148
days
Expert Perspective: Toward Treat‐to‐Target Management in Adult Idiopathic Inflammatory Myopathies
AuthorsShiri Keret; Nantakarn Pongtarakulpanit; Rohit Aggarwal
Affiliations1. Rheumatology unit, Bnai‐Zion Medical Center, Faculty of Medicine, Technion Haifa Israel; 2. Division of Rheumatology and Clinical Immunology University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA; 3. Division of Allergy, Immunology and Rheumatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital Mahidol University Bangkok Thailand
106
days
Age‐Specific Incidence of Systemic Lupus Erythematosus in the United States: A Meta‐Analysis of Data From the Centers for Disease Control and Prevention Lupus Registries
AuthorsPeter M. Izmirly; Elizabeth D. Ferucci; Aimee O. Hersh; Mary Beth Son; S. Sam Lim; Cristina Drenkard; Cynthia S. Crowson; Ali Duarte‐Garcia; Jill P. Buyon; Heather T. Gold; Maria Dall'Era; Patricia P. Katz; Laura C. Plantinga; Jinoos Yazdany; Emily C. Somers; Hilary Parton
Affiliations1. Division of Rheumatology, Department of Medicine New York University Grossman School of Medicine New York; 2. Division of Community Health Services, Department of Research Services Alaska Native Tribal Health Consortium Anchorage; 3. Division of Pediatric Rheumatology, Department of Pediatrics University of Utah Salt Lake City; 4. Division of Immunology, Department of Pediatrics Harvard Medical School Boston Massachusetts; 5. Division of Rheumatology, Department of Medicine Emory University Atlanta Georgia; 6. Division of Rheumatology, Department of Medicine Mayo Clinic Rochester Minnesota; 7. Department of Population Health New York University Grossman School of Medicine New York; 8. Division of Rheumatology, Department of Medicine University of California San Francisco; 9. Division of Rheumatology and Departments of Internal Medicine, Environmental Health Sciences, and Obstetrics and Gynecology University of Michigan Ann Arbor; 10. New York City Department of Health and Mental Hygiene Long Island City New York
208
days
Abatacept Reduces CD319 + ( SLAMF7 ) Cytotoxic T Cells and Cytokine Production in Systemic Sclerosis
AuthorsMikel Gurrea‐Rubio; Laura A. Cooney; Kohei Maeda; Phillip L. Campbell; Qi Wu; Camila I. Amarista; Alexander Stinson; Ray Ohara; Yang Mao‐Draayer; Michael L. Whitfield; Shiv Pillai; Poulami Dey; Johann E. Gudjonsson; Pei‐Suen Tsou; Dinesh Khanna; David A. Fox
Affiliations1. Department of Internal Medicine, Division of Rheumatology University of Michigan Ann Arbor; 2. Oklahoma Medical Research Foundation Oklahoma City; 3. Department of Biomedical Data Science Geisel School of Medicine at Dartmouth Lebanon New Hampshire; 4. Harvard Medical School Boston Massachusetts; 5. Department of Dermatology University of Michigan Ann Arbor; 6. Scleroderma Program University of Michigan Ann Arbor; 7. Autoimmunity Center of Excellence University of Michigan Ann Arbor
23
days
Local reasoning large language models for privacy‐preserving identification of systemic lupus erythematosus
AuthorsMehmet Hocaoǧlu; Amr H Sawalha
Affiliations1. Division of Rheumatology, and Clinical Immunology, Department of Medicine University of Pittsburgh Pittsburgh PA USA; 2. Lupus Center of Excellence University of Pittsburgh School of Medicine Pittsburgh PA USA; 3. Division of Rheumatology, Department of Pediatrics University of Pittsburgh Pittsburgh PA USA; 4. Department of Immunology University of Pittsburgh Pittsburgh PA USA
132
days
Updated COVID ‐19 Vaccines and Health Outcomes in Patients With Autoimmune Rheumatic Conditions
AuthorsLesley E. Jackson; A. Jerrod Anzalone; Kenneth G. Saag; Rahima Begum; AKM F. Rahman; Namrata Singh; Kaleb Michaud; Jasvinder A. Singh; Rena C. Patel; Maria I. Danila; the National Clinical Cohort Collaborative Consortium
Affiliations1. Division of Clinical Immunology and Rheumatology, Department of Medicine University of Alabama at Birmingham; 2. Rheumatology Birmingham VA Medical Center Birmingham Alabama; 3. Department of Biostatistics, College of Public Health University of Nebraska Medical Center Omaha; 4. Department of Biostatistics, School of Public Health University of Alabama at Birmingham; 5. Division of Rheumatology University of Washington Medical Center Seattle; 6. Division of Rheumatology, Department of Internal Medicine University of Nebraska Medical Center Omaha; 7. Medicine Service, Michael E. DeBakey VA Medical Center Houston Texas; 8. Department of Medicine Baylor College of Medicine Houston Texas; 9. Division of Infectious Diseases, Department of Medicine University of Alabama at Birmingham; 10. Geriatric Research Education and Clinical Center Birmingham VA Medical Center Birmingham Alabama
254
days
Risk of Cancer According to Duration of Targeted Therapy Exposure in Spondyloarthritis: A Nationwide Cohort Study From the French Health Insurance Database
AuthorsKarine Tankovic; Pascal Claudepierre; Tat Thang Vo; Tran Trong Khoi Le; Siham Iggui; Laetitia Penso; Emilie Sbidian; Laura Pina Vegas
Affiliations1. EPILOGY, Institut Mondor de Recherche Biomédicale, INSERM U955 Université Paris‐Est Créteil Créteil France; 2. Service de Rhumatologie, Hôpital Henri Mondor, AP‐HP Université Paris‐Est Créteil Créteil France; 3. Service de Dermatologie, Hôpital Henri Mondor, AP‐HP Université Paris‐Est Créteil Créteil France; 4. Centre d'Investigation Clinique 1430, INSERM Créteil France
111
days
Single‐cell RNA sequencing of peripheral blood defines two immunological subtypes of Sjögren's disease distinguished by anti‐SSA antibodies and aberrant B cell populations
AuthorsGeoffrey Urbanski; Kimberly E. Taylor; Emily Flynn; Armita Norouzi; Catherine Chu; Brittany Davidson; Arnab Ghosh; Joanne Nititham; Ravi K. Patel; Annie W. Poon; Gabriela K. Fragiadakis; Alexis J. Combes; Walter L. Eckalbar; Lindsey A. Criswell; Chun Jimmie Ye; Caroline H. Shiboski
Affiliations1. Department of Orofacial Sciences University of California San Francisco San Francisco CA USA; 2. UCSF CoLabs Initiative University of California San Francisco San Francisco CA USA; 3. Division of Immunology and Allergology, Laboratory of Translational Immunology, Department of Medicine, Hôpitaux Universitaires de Genève Geneva GE Switzerland; 4. Division of Rheumatology, Department of Medicine University of California San Francisco CA USA; 5. School of Medicine University of Washington Seattle WA USA; 6. National Human Genome Research Institute NIH Bethesda MD USA; 7. Bakar ImmunoX Initiative University of California San Francisco San Francisco CA USA; 8. Department of Pathology University of California San Francisco San Francisco CA USA; 9. Division of Gastroenterology, Department of Medicine University of California San Francisco San Francisco CA USA; 10. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine University of California San Francisco CA USA; 11. Institute for Human Genetics University of California, San Francisco San Francisco CA USA; 12. Department of Bioengineering and Therapeutic Sciences University of California San Francisco San Francisco CA USA; 13. Department of Epidemiology and Biostatistics University of California San Francisco San Francisco CA USA; 14. Chan Zuckerberg Biohub San Francisco CA USA
114
days
Nonmelanoma Skin Cancer Risk With JAK Inhibitors Compared to Interleukin‐6 Receptor Inhibitors in Rheumatoid Arthritis: Results From a National Cohort Study
AuthorsZixing Tian; Lianne Kearsley‐Fleet; Sizheng Steven Zhao; James Galloway; Mark Lunt; Kath Watson; Narges Azadbakht; British Society for Rheumatology Biologics Register in Rheumatoid Arthritis Contributors Group; Kimme L. Hyrich
Affiliations1. Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology Medicine and Health University of Manchester Manchester United Kingdom; 2. Manchester Academic Health Science Centre Manchester United Kingdom; 3. Centre for Rheumatic Diseases King's College London London United Kingdom; 4. Manchester Biomedical Research Centre, National Institute of Health Research Manchester University NHS Foundation Trust Manchester United Kingdom
205
days
The synergistic impact of granulocytic myeloid‐derived suppressor cells and innate lymphoid cells in systemic sclerosis
AuthorsStefanie Weber; Mario R. Angeli; Hashem Mohammadian; Hannah Labinsky; Maria Gabriella Raimondo; Richard Demmler; Yuko Ariza; Thomas Wohlfahrt; Markus Luber; Yi‐Nan Li; Jörg H.W. Distler; Tobias Bäuerle; Georg Schett; Simon Rauber; Andreas Ramming; Alina M. Ramming
Affiliations1. Department of Internal Medicine 3 ‐ Rheumatology and Immunology, Friedrich‐Alexander‐University (FAU) Erlangen‐Nürnberg and Universitätsklinikum Erlangen Erlangen Germany; 2. Deutsches Zentrum für Immuntherapie (DZI), Friedrich‐Alexander‐University (FAU) Erlangen‐Nürnberg and Universitätsklinikum Erlangen Erlangen Germany; 3. Department of Internal Medicine 2, Rheumatology and Clinical Immunology, Universitätsklinikum Würzburg Würzburg Germany; 4. Hiller Research Center University Hospital Düsseldorf Heinrich‐Heine University Düsseldorf Düsseldorf Germany; 5. Clinic for Rheumatology University Hospital Düsseldorf Heinrich‐Heine University Düsseldorf Düsseldorf Germany; 6. Institute of Radiology Friedrich‐Alexander‐University (FAU) Erlangen‐Nürnberg and Universitätsklinikum Erlangen Erlangen Germany; 7. Department of Radiology, Johannes‐Gutenberg‐Universität Mainz and Universitätsmedizin Mainz Mainz Germany; 8. Division of Rheumatology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days